AptarGroup Inc

Healthcare · Medical Instruments & Supplies

123.30$ -0.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

AptarGroup Inc (ATR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 5,253 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATR
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	576	585	715	863	952	915	1,048	1,264	1,374	1,357	1,592	1,912	1,832	1,956	2,033	2,159	2,324	2,498	2,437	2,437	2,607	3,138	3,378	3,562	3,990	4,141	4,203	4,452	4,432	5,253
Current Assets	237	256	317	351	408	375	447	602	661	605	763	1,003	860	943	1,064	1,144	1,039	1,198	1,214	1,295	1,270	1,670	1,331	1,291	1,369	1,358	1,430	1,549	1,478	1,894
Cash	16	18	25	32	56	48	90	165	170	118	171	314	192	333	376	378	230	310	400	490	466	713	262	242	300	123	142	224	224	402
Cash & Short-Term Investments	16	18	25	32	56	48	90	165	170	118	171	314	192	333	376	378	230	310	400	520	466	713	262	242	300	124	142	224	226	410
Receivables	131	145	173	189	211	185	198	232	267	260	321	361	344	320	357	389	397	438	407	392	433	510	570	558	567	671	677	678	658	804
Inventory	76	79	101	109	122	121	128	165	189	184	226	273	245	231	272	285	322	353	311	295	297	337	381	376	379	441	487	513	462	538
Property, Plant & Equipment	–	–	–	–	377	381	435	483	535	537	591	657	721	764	725	755	848	865	812	765	784	868	992	1,088	1,269	1,276	1,402	1,537	1,511	1,676
Goodwill	–	–	–	–	128	123	129	137	140	185	208	223	227	231	227	234	352	359	330	310	408	444	712	763	899	974	946	963	936	1,078
Intangible Assets	47	41	50	127	128	123	144	151	14	17	20	25	23	9.1	5.2	4.4	52	50	40	32	94	95	255	291	344	362	316	283	255	255
Total Liabilities	236	239	295	439	507	441	448	475	494	543	645	792	700	703	753	869	944	1,017	1,333	1,287	1,433	1,826	1,955	1,990	2,139	2,157	2,135	2,131	1,946	2,540
Current Liabilities	116	125	167	160	203	154	163	283	277	321	400	565	375	417	423	519	455	543	605	412	543	528	689	683	780	982	917	1,251	1,068	1,166
Short-Term Debt	14	2.9	37	35	40	13	7.7	97	63	102	127	216	65	128	146	184	75	140	253	57	175	67	164	110	118	290	126	458	338	344
Accounts Payable	103	123	66	125	164	141	155	187	214	219	273	349	134	109	124	109	137	150	116	115	116	154	165	193	244	285	320	329	296	341
Long-Term Debt	–	–	–	–	253	239	219	125	143	145	169	147	227	210	259	255	353	355	589	761	772	1,191	1,126	1,085	1,055	907	1,053	681	688	1,139
Shareholders' Equity	336	342	416	420	441	469	594	783	873	809	946	1,119	1,131	1,253	1,279	1,290	1,380	1,480	1,103	1,149	1,174	1,312	1,423	1,572	1,850	1,969	2,054	2,307	2,472	2,668
Retained Earnings	233	275	330	382	439	490	548	619	696	771	845	951	1,066	1,150	1,279	1,409	1,514	1,619	1,740	1,186	1,197	1,301	1,372	1,524	1,644	1,789	1,929	2,110	2,371	2,643
Shares Outstanding	72	73	74	74	73	73	73	74	74	72	72	72	71	70	70	69	68	68	67	64	65	65	65	66	67	68	67	67	68	67

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings